nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—Isoprenaline—MAPK1—ovarian cancer	0.0135	1	CrCbGaD
Formoterol—Rash—Melphalan—ovarian cancer	0.00109	0.0011	CcSEcCtD
Formoterol—Dermatitis—Melphalan—ovarian cancer	0.00108	0.0011	CcSEcCtD
Formoterol—Cough—Paclitaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Formoterol—Asthenia—Vinorelbine—ovarian cancer	0.00108	0.00109	CcSEcCtD
Formoterol—Dry skin—Epirubicin—ovarian cancer	0.00108	0.00109	CcSEcCtD
Formoterol—Arrhythmia—Docetaxel—ovarian cancer	0.00108	0.00109	CcSEcCtD
Formoterol—Hypokalaemia—Epirubicin—ovarian cancer	0.00107	0.00109	CcSEcCtD
Formoterol—Hypertension—Paclitaxel—ovarian cancer	0.00107	0.00109	CcSEcCtD
Formoterol—Pruritus—Vinorelbine—ovarian cancer	0.00106	0.00108	CcSEcCtD
Formoterol—Mental disorder—Docetaxel—ovarian cancer	0.00106	0.00107	CcSEcCtD
Formoterol—Chest pain—Paclitaxel—ovarian cancer	0.00106	0.00107	CcSEcCtD
Formoterol—Myalgia—Paclitaxel—ovarian cancer	0.00106	0.00107	CcSEcCtD
Formoterol—Arthralgia—Paclitaxel—ovarian cancer	0.00106	0.00107	CcSEcCtD
Formoterol—Nasopharyngitis—Epirubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Formoterol—Anxiety—Paclitaxel—ovarian cancer	0.00105	0.00107	CcSEcCtD
Formoterol—Malnutrition—Docetaxel—ovarian cancer	0.00105	0.00107	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00105	0.00106	CcSEcCtD
Formoterol—Nausea—Topotecan—ovarian cancer	0.00104	0.00106	CcSEcCtD
Formoterol—Discomfort—Paclitaxel—ovarian cancer	0.00104	0.00106	CcSEcCtD
Formoterol—Gastritis—Epirubicin—ovarian cancer	0.00104	0.00106	CcSEcCtD
Formoterol—Dry mouth—Paclitaxel—ovarian cancer	0.00103	0.00105	CcSEcCtD
Formoterol—Diarrhoea—Vinorelbine—ovarian cancer	0.00103	0.00104	CcSEcCtD
Formoterol—Dysgeusia—Docetaxel—ovarian cancer	0.00103	0.00104	CcSEcCtD
Formoterol—Nausea—Melphalan—ovarian cancer	0.00102	0.00104	CcSEcCtD
Formoterol—Influenza—Epirubicin—ovarian cancer	0.00102	0.00103	CcSEcCtD
Formoterol—Asthma—Epirubicin—ovarian cancer	0.00102	0.00103	CcSEcCtD
Formoterol—Back pain—Docetaxel—ovarian cancer	0.00102	0.00103	CcSEcCtD
Formoterol—Dehydration—Doxorubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Formoterol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Formoterol—Oedema—Paclitaxel—ovarian cancer	0.00101	0.00103	CcSEcCtD
Formoterol—Muscle spasms—Docetaxel—ovarian cancer	0.00101	0.00102	CcSEcCtD
Formoterol—Infection—Paclitaxel—ovarian cancer	0.00101	0.00102	CcSEcCtD
Formoterol—Dry skin—Doxorubicin—ovarian cancer	0.000998	0.00101	CcSEcCtD
Formoterol—Dizziness—Vinorelbine—ovarian cancer	0.000995	0.00101	CcSEcCtD
Formoterol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000992	0.00101	CcSEcCtD
Formoterol—Hypokalaemia—Doxorubicin—ovarian cancer	0.000991	0.001	CcSEcCtD
Formoterol—Angina pectoris—Epirubicin—ovarian cancer	0.000991	0.001	CcSEcCtD
Formoterol—Tachycardia—Paclitaxel—ovarian cancer	0.000988	0.001	CcSEcCtD
Formoterol—Skin disorder—Paclitaxel—ovarian cancer	0.000983	0.000996	CcSEcCtD
Formoterol—Bronchitis—Epirubicin—ovarian cancer	0.000978	0.000992	CcSEcCtD
Formoterol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000974	0.000987	CcSEcCtD
Formoterol—Gastritis—Doxorubicin—ovarian cancer	0.000964	0.000977	CcSEcCtD
Formoterol—Vomiting—Vinorelbine—ovarian cancer	0.000957	0.00097	CcSEcCtD
Formoterol—Rash—Vinorelbine—ovarian cancer	0.000949	0.000962	CcSEcCtD
Formoterol—Dermatitis—Vinorelbine—ovarian cancer	0.000948	0.000961	CcSEcCtD
Formoterol—Hypotension—Paclitaxel—ovarian cancer	0.000946	0.000959	CcSEcCtD
Formoterol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000946	0.000959	CcSEcCtD
Formoterol—Headache—Vinorelbine—ovarian cancer	0.000943	0.000955	CcSEcCtD
Formoterol—Asthma—Doxorubicin—ovarian cancer	0.000941	0.000954	CcSEcCtD
Formoterol—Influenza—Doxorubicin—ovarian cancer	0.000941	0.000954	CcSEcCtD
Formoterol—Palpitations—Docetaxel—ovarian cancer	0.000929	0.000941	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000922	0.000935	CcSEcCtD
Formoterol—Hyperglycaemia—Epirubicin—ovarian cancer	0.000918	0.00093	CcSEcCtD
Formoterol—Cough—Docetaxel—ovarian cancer	0.000917	0.00093	CcSEcCtD
Formoterol—Angina pectoris—Doxorubicin—ovarian cancer	0.000917	0.00093	CcSEcCtD
Formoterol—Insomnia—Paclitaxel—ovarian cancer	0.000915	0.000928	CcSEcCtD
Formoterol—Hypertension—Docetaxel—ovarian cancer	0.000907	0.00092	CcSEcCtD
Formoterol—Bronchitis—Doxorubicin—ovarian cancer	0.000905	0.000918	CcSEcCtD
Formoterol—Dyspnoea—Paclitaxel—ovarian cancer	0.000902	0.000915	CcSEcCtD
Formoterol—Somnolence—Paclitaxel—ovarian cancer	0.0009	0.000912	CcSEcCtD
Formoterol—Myalgia—Docetaxel—ovarian cancer	0.000895	0.000907	CcSEcCtD
Formoterol—Arthralgia—Docetaxel—ovarian cancer	0.000895	0.000907	CcSEcCtD
Formoterol—Chest pain—Docetaxel—ovarian cancer	0.000895	0.000907	CcSEcCtD
Formoterol—Nausea—Vinorelbine—ovarian cancer	0.000894	0.000906	CcSEcCtD
Formoterol—Dyspepsia—Paclitaxel—ovarian cancer	0.000891	0.000903	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000889	0.000901	CcSEcCtD
Formoterol—Conjunctivitis—Epirubicin—ovarian cancer	0.000882	0.000894	CcSEcCtD
Formoterol—Urinary tract infection—Epirubicin—ovarian cancer	0.000882	0.000894	CcSEcCtD
Formoterol—Dry mouth—Docetaxel—ovarian cancer	0.000875	0.000887	CcSEcCtD
Formoterol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000875	0.000887	CcSEcCtD
Formoterol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000874	0.000886	CcSEcCtD
Formoterol—Fatigue—Paclitaxel—ovarian cancer	0.000872	0.000884	CcSEcCtD
Formoterol—Pain—Paclitaxel—ovarian cancer	0.000865	0.000877	CcSEcCtD
Formoterol—Constipation—Paclitaxel—ovarian cancer	0.000865	0.000877	CcSEcCtD
Formoterol—Haematuria—Epirubicin—ovarian cancer	0.000865	0.000877	CcSEcCtD
Formoterol—Oedema—Docetaxel—ovarian cancer	0.000858	0.000869	CcSEcCtD
Formoterol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000858	0.000869	CcSEcCtD
Formoterol—Infection—Docetaxel—ovarian cancer	0.000852	0.000864	CcSEcCtD
Formoterol—Sinusitis—Epirubicin—ovarian cancer	0.000851	0.000863	CcSEcCtD
Formoterol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000849	0.000861	CcSEcCtD
Formoterol—Nervous system disorder—Docetaxel—ovarian cancer	0.000841	0.000853	CcSEcCtD
Formoterol—Tachycardia—Docetaxel—ovarian cancer	0.000837	0.000849	CcSEcCtD
Formoterol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000834	0.000845	CcSEcCtD
Formoterol—Skin disorder—Docetaxel—ovarian cancer	0.000833	0.000845	CcSEcCtD
Formoterol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000828	0.000839	CcSEcCtD
Formoterol—Rhinitis—Epirubicin—ovarian cancer	0.000816	0.000828	CcSEcCtD
Formoterol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000816	0.000827	CcSEcCtD
Formoterol—Urinary tract infection—Doxorubicin—ovarian cancer	0.000816	0.000827	CcSEcCtD
Formoterol—Pharyngitis—Epirubicin—ovarian cancer	0.000808	0.000819	CcSEcCtD
Formoterol—Urinary tract disorder—Epirubicin—ovarian cancer	0.000804	0.000815	CcSEcCtD
Formoterol—Urticaria—Paclitaxel—ovarian cancer	0.000804	0.000815	CcSEcCtD
Formoterol—Oedema peripheral—Epirubicin—ovarian cancer	0.000802	0.000813	CcSEcCtD
Formoterol—Hypotension—Docetaxel—ovarian cancer	0.000802	0.000812	CcSEcCtD
Formoterol—Haematuria—Doxorubicin—ovarian cancer	0.0008	0.000811	CcSEcCtD
Formoterol—Connective tissue disorder—Epirubicin—ovarian cancer	0.0008	0.000811	CcSEcCtD
Formoterol—Abdominal pain—Paclitaxel—ovarian cancer	0.0008	0.000811	CcSEcCtD
Formoterol—Body temperature increased—Paclitaxel—ovarian cancer	0.0008	0.000811	CcSEcCtD
Formoterol—Urethral disorder—Epirubicin—ovarian cancer	0.000798	0.000809	CcSEcCtD
Formoterol—Sinusitis—Doxorubicin—ovarian cancer	0.000787	0.000798	CcSEcCtD
Formoterol—Visual impairment—Epirubicin—ovarian cancer	0.000785	0.000796	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000781	0.000792	CcSEcCtD
Formoterol—Insomnia—Docetaxel—ovarian cancer	0.000776	0.000786	CcSEcCtD
Formoterol—Dyspnoea—Docetaxel—ovarian cancer	0.000765	0.000775	CcSEcCtD
Formoterol—Somnolence—Docetaxel—ovarian cancer	0.000763	0.000773	CcSEcCtD
Formoterol—Cardiac disorder—Epirubicin—ovarian cancer	0.000756	0.000766	CcSEcCtD
Formoterol—Rhinitis—Doxorubicin—ovarian cancer	0.000755	0.000766	CcSEcCtD
Formoterol—Dyspepsia—Docetaxel—ovarian cancer	0.000755	0.000765	CcSEcCtD
Formoterol—Pharyngitis—Doxorubicin—ovarian cancer	0.000748	0.000758	CcSEcCtD
Formoterol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000746	0.000756	CcSEcCtD
Formoterol—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000744	0.000754	CcSEcCtD
Formoterol—Oedema peripheral—Doxorubicin—ovarian cancer	0.000742	0.000752	CcSEcCtD
Formoterol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000741	0.000751	CcSEcCtD
Formoterol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00074	0.000751	CcSEcCtD
Formoterol—Fatigue—Docetaxel—ovarian cancer	0.00074	0.00075	CcSEcCtD
Formoterol—Urethral disorder—Doxorubicin—ovarian cancer	0.000739	0.000749	CcSEcCtD
Formoterol—Immune system disorder—Epirubicin—ovarian cancer	0.000736	0.000746	CcSEcCtD
Formoterol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000734	0.000744	CcSEcCtD
Formoterol—Constipation—Docetaxel—ovarian cancer	0.000734	0.000744	CcSEcCtD
Formoterol—Pain—Docetaxel—ovarian cancer	0.000734	0.000744	CcSEcCtD
Formoterol—Arrhythmia—Epirubicin—ovarian cancer	0.000727	0.000737	CcSEcCtD
Formoterol—Visual impairment—Doxorubicin—ovarian cancer	0.000726	0.000736	CcSEcCtD
Formoterol—Asthenia—Paclitaxel—ovarian cancer	0.000726	0.000736	CcSEcCtD
Formoterol—Pruritus—Paclitaxel—ovarian cancer	0.000716	0.000726	CcSEcCtD
Formoterol—Mental disorder—Epirubicin—ovarian cancer	0.000713	0.000723	CcSEcCtD
Formoterol—Malnutrition—Epirubicin—ovarian cancer	0.000709	0.000719	CcSEcCtD
Formoterol—Feeling abnormal—Docetaxel—ovarian cancer	0.000707	0.000717	CcSEcCtD
Formoterol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000701	0.000711	CcSEcCtD
Formoterol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000699	0.000709	CcSEcCtD
Formoterol—Tension—Epirubicin—ovarian cancer	0.000696	0.000705	CcSEcCtD
Formoterol—Dysgeusia—Epirubicin—ovarian cancer	0.000694	0.000704	CcSEcCtD
Formoterol—Diarrhoea—Paclitaxel—ovarian cancer	0.000692	0.000702	CcSEcCtD
Formoterol—Nervousness—Epirubicin—ovarian cancer	0.000689	0.000698	CcSEcCtD
Formoterol—Back pain—Epirubicin—ovarian cancer	0.000686	0.000695	CcSEcCtD
Formoterol—Muscle spasms—Epirubicin—ovarian cancer	0.000682	0.000691	CcSEcCtD
Formoterol—Immune system disorder—Doxorubicin—ovarian cancer	0.000681	0.00069	CcSEcCtD
Formoterol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000679	0.000688	CcSEcCtD
Formoterol—Abdominal pain—Docetaxel—ovarian cancer	0.000678	0.000687	CcSEcCtD
Formoterol—Body temperature increased—Docetaxel—ovarian cancer	0.000678	0.000687	CcSEcCtD
Formoterol—Arrhythmia—Doxorubicin—ovarian cancer	0.000673	0.000682	CcSEcCtD
Formoterol—Dizziness—Paclitaxel—ovarian cancer	0.000669	0.000678	CcSEcCtD
Formoterol—Mental disorder—Doxorubicin—ovarian cancer	0.00066	0.000669	CcSEcCtD
Formoterol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000658	0.000667	CcSEcCtD
Formoterol—Malnutrition—Doxorubicin—ovarian cancer	0.000656	0.000665	CcSEcCtD
Formoterol—Agitation—Epirubicin—ovarian cancer	0.000651	0.00066	CcSEcCtD
Formoterol—Tension—Doxorubicin—ovarian cancer	0.000644	0.000652	CcSEcCtD
Formoterol—Vomiting—Paclitaxel—ovarian cancer	0.000643	0.000652	CcSEcCtD
Formoterol—Dysgeusia—Doxorubicin—ovarian cancer	0.000642	0.000651	CcSEcCtD
Formoterol—Malaise—Epirubicin—ovarian cancer	0.000639	0.000648	CcSEcCtD
Formoterol—Rash—Paclitaxel—ovarian cancer	0.000638	0.000647	CcSEcCtD
Formoterol—Dermatitis—Paclitaxel—ovarian cancer	0.000637	0.000646	CcSEcCtD
Formoterol—Nervousness—Doxorubicin—ovarian cancer	0.000637	0.000646	CcSEcCtD
Formoterol—Back pain—Doxorubicin—ovarian cancer	0.000634	0.000643	CcSEcCtD
Formoterol—Headache—Paclitaxel—ovarian cancer	0.000634	0.000643	CcSEcCtD
Formoterol—Hypersensitivity—Docetaxel—ovarian cancer	0.000632	0.000641	CcSEcCtD
Formoterol—Muscle spasms—Doxorubicin—ovarian cancer	0.000631	0.000639	CcSEcCtD
Formoterol—Palpitations—Epirubicin—ovarian cancer	0.000626	0.000635	CcSEcCtD
Formoterol—Cough—Epirubicin—ovarian cancer	0.000619	0.000627	CcSEcCtD
Formoterol—Asthenia—Docetaxel—ovarian cancer	0.000615	0.000624	CcSEcCtD
Formoterol—Hypertension—Epirubicin—ovarian cancer	0.000612	0.00062	CcSEcCtD
Formoterol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000609	0.000617	CcSEcCtD
Formoterol—Pruritus—Docetaxel—ovarian cancer	0.000607	0.000615	CcSEcCtD
Formoterol—Chest pain—Epirubicin—ovarian cancer	0.000604	0.000612	CcSEcCtD
Formoterol—Myalgia—Epirubicin—ovarian cancer	0.000604	0.000612	CcSEcCtD
Formoterol—Arthralgia—Epirubicin—ovarian cancer	0.000604	0.000612	CcSEcCtD
Formoterol—Agitation—Doxorubicin—ovarian cancer	0.000603	0.000611	CcSEcCtD
Formoterol—Anxiety—Epirubicin—ovarian cancer	0.000601	0.00061	CcSEcCtD
Formoterol—Nausea—Paclitaxel—ovarian cancer	0.000601	0.000609	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000599	0.000608	CcSEcCtD
Formoterol—Discomfort—Epirubicin—ovarian cancer	0.000596	0.000604	CcSEcCtD
Formoterol—Malaise—Doxorubicin—ovarian cancer	0.000592	0.0006	CcSEcCtD
Formoterol—Dry mouth—Epirubicin—ovarian cancer	0.00059	0.000598	CcSEcCtD
Formoterol—Diarrhoea—Docetaxel—ovarian cancer	0.000587	0.000595	CcSEcCtD
Formoterol—Palpitations—Doxorubicin—ovarian cancer	0.00058	0.000588	CcSEcCtD
Formoterol—Anaphylactic shock—Epirubicin—ovarian cancer	0.000579	0.000586	CcSEcCtD
Formoterol—Oedema—Epirubicin—ovarian cancer	0.000579	0.000586	CcSEcCtD
Formoterol—Infection—Epirubicin—ovarian cancer	0.000575	0.000583	CcSEcCtD
Formoterol—Cough—Doxorubicin—ovarian cancer	0.000572	0.00058	CcSEcCtD
Formoterol—Nervous system disorder—Epirubicin—ovarian cancer	0.000567	0.000575	CcSEcCtD
Formoterol—Dizziness—Docetaxel—ovarian cancer	0.000567	0.000575	CcSEcCtD
Formoterol—Hypertension—Doxorubicin—ovarian cancer	0.000566	0.000574	CcSEcCtD
Formoterol—Tachycardia—Epirubicin—ovarian cancer	0.000565	0.000572	CcSEcCtD
Formoterol—Skin disorder—Epirubicin—ovarian cancer	0.000562	0.00057	CcSEcCtD
Formoterol—Arthralgia—Doxorubicin—ovarian cancer	0.000558	0.000566	CcSEcCtD
Formoterol—Chest pain—Doxorubicin—ovarian cancer	0.000558	0.000566	CcSEcCtD
Formoterol—Myalgia—Doxorubicin—ovarian cancer	0.000558	0.000566	CcSEcCtD
Formoterol—Anxiety—Doxorubicin—ovarian cancer	0.000557	0.000564	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000555	0.000562	CcSEcCtD
Formoterol—Discomfort—Doxorubicin—ovarian cancer	0.000552	0.000559	CcSEcCtD
Formoterol—Dry mouth—Doxorubicin—ovarian cancer	0.000546	0.000554	CcSEcCtD
Formoterol—Vomiting—Docetaxel—ovarian cancer	0.000545	0.000553	CcSEcCtD
Formoterol—Rash—Docetaxel—ovarian cancer	0.000541	0.000548	CcSEcCtD
Formoterol—Hypotension—Epirubicin—ovarian cancer	0.000541	0.000548	CcSEcCtD
Formoterol—Dermatitis—Docetaxel—ovarian cancer	0.00054	0.000548	CcSEcCtD
Formoterol—Headache—Docetaxel—ovarian cancer	0.000537	0.000545	CcSEcCtD
Formoterol—Oedema—Doxorubicin—ovarian cancer	0.000535	0.000543	CcSEcCtD
Formoterol—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000535	0.000543	CcSEcCtD
Formoterol—Infection—Doxorubicin—ovarian cancer	0.000532	0.000539	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000527	0.000534	CcSEcCtD
Formoterol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000525	0.000532	CcSEcCtD
Formoterol—Insomnia—Epirubicin—ovarian cancer	0.000523	0.00053	CcSEcCtD
Formoterol—Tachycardia—Doxorubicin—ovarian cancer	0.000522	0.00053	CcSEcCtD
Formoterol—Skin disorder—Doxorubicin—ovarian cancer	0.00052	0.000527	CcSEcCtD
Formoterol—Dyspnoea—Epirubicin—ovarian cancer	0.000516	0.000523	CcSEcCtD
Formoterol—Somnolence—Epirubicin—ovarian cancer	0.000514	0.000521	CcSEcCtD
Formoterol—Nausea—Docetaxel—ovarian cancer	0.00051	0.000516	CcSEcCtD
Formoterol—Dyspepsia—Epirubicin—ovarian cancer	0.000509	0.000516	CcSEcCtD
Formoterol—Hypotension—Doxorubicin—ovarian cancer	0.0005	0.000507	CcSEcCtD
Formoterol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000499	0.000506	CcSEcCtD
Formoterol—Fatigue—Epirubicin—ovarian cancer	0.000499	0.000506	CcSEcCtD
Formoterol—Constipation—Epirubicin—ovarian cancer	0.000495	0.000502	CcSEcCtD
Formoterol—Pain—Epirubicin—ovarian cancer	0.000495	0.000502	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000488	0.000494	CcSEcCtD
Formoterol—Insomnia—Doxorubicin—ovarian cancer	0.000484	0.000491	CcSEcCtD
Formoterol—Dyspnoea—Doxorubicin—ovarian cancer	0.000477	0.000484	CcSEcCtD
Formoterol—Feeling abnormal—Epirubicin—ovarian cancer	0.000477	0.000483	CcSEcCtD
Formoterol—Somnolence—Doxorubicin—ovarian cancer	0.000476	0.000482	CcSEcCtD
Formoterol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000473	0.00048	CcSEcCtD
Formoterol—Dyspepsia—Doxorubicin—ovarian cancer	0.000471	0.000478	CcSEcCtD
Formoterol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000462	0.000468	CcSEcCtD
Formoterol—Fatigue—Doxorubicin—ovarian cancer	0.000462	0.000468	CcSEcCtD
Formoterol—Urticaria—Epirubicin—ovarian cancer	0.00046	0.000466	CcSEcCtD
Formoterol—Constipation—Doxorubicin—ovarian cancer	0.000458	0.000464	CcSEcCtD
Formoterol—Pain—Doxorubicin—ovarian cancer	0.000458	0.000464	CcSEcCtD
Formoterol—Abdominal pain—Epirubicin—ovarian cancer	0.000457	0.000464	CcSEcCtD
Formoterol—Body temperature increased—Epirubicin—ovarian cancer	0.000457	0.000464	CcSEcCtD
Formoterol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000441	0.000447	CcSEcCtD
Formoterol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000438	0.000444	CcSEcCtD
Formoterol—Hypersensitivity—Epirubicin—ovarian cancer	0.000426	0.000432	CcSEcCtD
Formoterol—Urticaria—Doxorubicin—ovarian cancer	0.000425	0.000431	CcSEcCtD
Formoterol—Abdominal pain—Doxorubicin—ovarian cancer	0.000423	0.000429	CcSEcCtD
Formoterol—Body temperature increased—Doxorubicin—ovarian cancer	0.000423	0.000429	CcSEcCtD
Formoterol—Asthenia—Epirubicin—ovarian cancer	0.000415	0.000421	CcSEcCtD
Formoterol—Pruritus—Epirubicin—ovarian cancer	0.000409	0.000415	CcSEcCtD
Formoterol—Diarrhoea—Epirubicin—ovarian cancer	0.000396	0.000401	CcSEcCtD
Formoterol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000394	0.0004	CcSEcCtD
Formoterol—Asthenia—Doxorubicin—ovarian cancer	0.000384	0.000389	CcSEcCtD
Formoterol—Dizziness—Epirubicin—ovarian cancer	0.000383	0.000388	CcSEcCtD
Formoterol—Pruritus—Doxorubicin—ovarian cancer	0.000379	0.000384	CcSEcCtD
Formoterol—Vomiting—Epirubicin—ovarian cancer	0.000368	0.000373	CcSEcCtD
Formoterol—Diarrhoea—Doxorubicin—ovarian cancer	0.000366	0.000371	CcSEcCtD
Formoterol—Rash—Epirubicin—ovarian cancer	0.000365	0.00037	CcSEcCtD
Formoterol—Dermatitis—Epirubicin—ovarian cancer	0.000364	0.000369	CcSEcCtD
Formoterol—Headache—Epirubicin—ovarian cancer	0.000362	0.000367	CcSEcCtD
Formoterol—Dizziness—Doxorubicin—ovarian cancer	0.000354	0.000359	CcSEcCtD
Formoterol—Nausea—Epirubicin—ovarian cancer	0.000344	0.000348	CcSEcCtD
Formoterol—Vomiting—Doxorubicin—ovarian cancer	0.00034	0.000345	CcSEcCtD
Formoterol—Rash—Doxorubicin—ovarian cancer	0.000338	0.000342	CcSEcCtD
Formoterol—Dermatitis—Doxorubicin—ovarian cancer	0.000337	0.000342	CcSEcCtD
Formoterol—Headache—Doxorubicin—ovarian cancer	0.000335	0.00034	CcSEcCtD
Formoterol—Nausea—Doxorubicin—ovarian cancer	0.000318	0.000322	CcSEcCtD
